La Jollas fabled Salk Institute says its in great financial shape. Just two years ago, it raised a record $361 million in private donations far exceeding its goal.
But a short time later, the Salk noted in private documents that it still faces daunting money issues that come as it tries to preserve the singular approach it takes to studying human disease.
Like other biomedical research institutes, the Salk is under great pressure to develop discoveries to the point where they will attract big money from drug companies, the government and appreciative donors.
The people who underwrite science say scientists can and must speed up the process of finding ways to alleviate suffering.
The 57-year-old Salk has long preferred to focus on more basic questions about how and why disease occurs work that has aided in the creation of such cancer drugs as Gleevec and Iressa. Its painstaking research that doesnt always have a clear payoff, and can make it hard to compete for money.
The challenge comes as the Salk is coping with the fallout from three of its female professors filing lawsuits that accuse the institute of gender discrimination. The suits, filed in July, say the Salk favors men when it comes to pay, promotions, grants and leadership opportunities.
The allegations have been staunchly denied by Salk President Elizabeth Blackburn, a Nobel laureate.
The matter was further complicated on Friday when Ted Waitt, the billionaire who chairs the Salks board of trustees, unexpectedly announced that he will leave the position in November for personal reasons.
Waitt played a key role in helping the Salk raise $361 million in private donations during a capital campaign that ended in 2015. His announcement came a day before the institute holds Symphony for Salk, a community-building concert held every August.
Theres broad agreement that the Salk, which is determined to remain small, needs to raise a lot more money for everything from recruiting faculty to buying pricey scientific equipment.
Despite the success of the recent capital campaign, there are significant and daunting financial challenges facing the institute, many which need to be addressed through increased private philanthropy, the Salk says in internal documents obtained by the Union-Tribune.
Documents: Salk Finances
The documents also show that, over the past couple of years, the Salk has considered a number of provocative ideas for dealing with the issue, including:
The Salk told the Union-Tribune on Thursday, The document leaked to you includes the preliminary brainstorming of several individuals holding various positions within Salk, including a number not serving in faculty or management roles, who were invited to present a wide-range of ideas for early consideration.
In no way is it equivalent to a strategic plan, which remains in development. It is simply a collection of initial thoughts.
Without question, the Salk Institute, in many ways, is now in the best financial and operational position it has ever been. It is entirely inaccurate and irresponsible to suggest otherwise.
The institute added that it decided not to pursue a short-term endowment campaign, a hospital affiliation, or a name change.
The Salk is charting its future at a moment when its scientific neighbors in La Jolla are rapidly expanding in translational medicine, the term for turning discoveries into drugs and therapies.
Theyre being driven, in part, by big donors who want scientists to shorten the time it takes to develop treatments for everything from dementia and cancer to diabetes, spinal cord injuries and aging.
The demand has been pressed especially hard by donors like T. Denny Sanford, who gave UC San Diego $100 million in 2013 to speed up the quest to find ways to use stem cells to treat a variety of afflictions.
Sanford said, It is time to move stem cell research from animals into humans for trials, especially in areas like ALS (Lou Gehrigs disease) and spinal cord injuries, where I believe we can make a lot of progress.
His gift helped the university create a seven-story translational medicine building thats physically linked to the new Jacobs Medical Center to make it easier for researchers and clinicians to collaborate.
Researchers there are doing such things as using smartphones to help determine the severity of cystic fibrosis in patients, and developing devices similar to the medical tri-corder seen in Star Trek.
The new building also has enabled UC San Diego to carry out drug trials, which helped the university raise a record $1.12 billion in research funding last year. And it helped the campus recruit such star scientists as Jeremy Rich, a brain tumor specialist who came from the Cleveland Clinic in Ohio.
A lot of people think that taking an idea or discovery from lab to clinic is simple. Its not; its almost impossibly difficult and exhausting, said Gary Firestein, the universitys associate vice chancellor of translational medicine.
The problem isnt just the science, but also the regulatory maze that stands between scientist and patient, he added. Translational medicine was invented to somehow bridge that gap.
The struggle has been playing out at places like The Scripps Research Institute (TSRI) in La Jolla, which is led by CEO Peter G. Schultz, an accomplished chemist also at home in the business world.
Schultz brought in an affiliate called Calibr to advance research to the clinical trial stage, where therapies are first tested in people. At that point much of the risk in development is gone, and drug companies will pay more to license products.
Earlier this year, Schultz revamped TSRIs board of directors to include more biomedical and business leaders and wealthy individuals. This high-powered board provides not only more credibility, but has members with money to make large donations themselves.
If Schultz achieves his goals, the institute will greatly speed up its pipeline of therapies from the laboratory bench to the patients bedside. That means patients will get new therapies faster and TSRI will get more money to continue churning out discoveries.
The Salk Institute faces pressure to do likewise, or be left behind. And it clearly sees this as a pivotal moment in its history. The institute summed up the challenge in a document obtained by the Union-Tribune.
A part of the document asks, simply: How do we make sure Salk is financially prepared to continue to be a leader in biological research?
For further reading
Salk board chairman stepping down amid institute turmoil
Salk president softens criticism of 2 faculty who sued for gender discrimination
Gender discrimination controversy grows at fabled Salk Institute
Salk Institute strikes back in gender discrimination feud
Salk Institute hires two noted researchers
From one cell to billions: Juan Carlos Izpisa Belmonte studies all stages of life
Salk Institute, UCSD scientists decode DNA's 3D shape
Scripps, Salk scientists independently make key biological advance
Twitter: @grobbins
gary.robbins@sduniontribune.com
See more here:
Salk faces 'daunting' need for money despite big success with ... - The San Diego Union-Tribune
- Making Blood Stem Cells on a Microchip: Academic Minute - December 27th, 2022
- Novel detection of stem cell niche within the stroma of limbus in the rabbit during postnatal development | Scientific Reports - Nature.com - August 14th, 2022
- Why Nebraska's U.S. Airmen have filed a lawsuit refusing the COVID-19 vaccine - KETV Omaha - July 27th, 2022
- Hepatic stellate cells in liver development, regeneration, and cancer - July 11th, 2022
- Fasting triggers stem cell regeneration of damaged, old immune system ... - June 13th, 2022
- Columbus man to be one of first to receive transplant via new OhioHealth program - 10TV - April 19th, 2022
- Grayson authorizes more than $1 million for ongoing and new equine research in 2022 - EQUUS Magazine - March 25th, 2022
- Cancer stem cells in glioblastoma - January 20th, 2022
- First-responder cells after heart attack prompt ... - January 20th, 2022
- New clinical trials from University Hospitals Seidman Cancer Center to begin with human protein following successful on-site approach to producing and... - December 24th, 2021
- Riverside Biologics Health Review: At Home "Stem Cells ... - December 24th, 2021
- China-bound Graduate Focused on Global Goals - University of Mary Washington - December 10th, 2021
- Mustang Bio to Host Key Opinion Leader Webinar on MB-106, a Potential Treatment for B-Cell Non Hodgkin Lymphomas and Chronic Lymphocytic Leukemia -... - December 10th, 2021
- Fruit Cells, Space Bread, and Cultured Meat Cartridges: Deep Space Food Challenge Announces Phase 1 Winners - The Spoon - October 28th, 2021
- Fungi foray: Wild mushrooms are a key part of food chain - Farm and Dairy - August 5th, 2021
- AgeX Therapeutics Inc. (NYSE:AGE) stock surged in the premarket trading session; heres why - Market Globalist - May 13th, 2021
- University Hospitals treats first cancer patient in Ohio with "game changing" CAR T therapy - News 5 Cleveland - May 13th, 2021
- Weekly line: What the new coronavirus variants mean for vaccines, transmission, and more - The Daily Briefing - January 20th, 2021
- Forge Biologics Announces FDA Clearance of Investigational New Drug Application for Phase 1/2 Clinical Trial (RESKUE) of FBX-101 Gene Therapy for... - January 9th, 2021
- The Rise of Steve Sarkisian ... And the Decline of the Man Who Got Him Here - Sports Illustrated - January 9th, 2021
- Raleigh man delivers stem cells to patients around the world - WRAL.com - November 28th, 2020
- A real life Superman celebrates 5 years of survival from one of the deadliest cancers - Newswise - November 28th, 2020
- The Museum That Fell From the Sky | History - Air & Space Magazine - November 28th, 2020
- A Detroit Lions VP tries to avoid wasting her daughter from uncommon illness - The Shepherd of the Hills Gazette - November 28th, 2020
- US biotechnology company races to get its COVID-19 therapeutic approved for access, which has previously shown positive results in severely ill... - November 5th, 2020
- STEM CELLS - Regenerative Medicine Institute of Ohio - October 18th, 2020
- FDA Grants Orphan Drug Designation to Novel Bcl-2 inhibitor in CLL - Targeted Oncology - September 9th, 2020
- Breastfeeding 'even better than previously thought' - The Irish News - The Irish News - June 29th, 2020
- Regenerative Therapy Options for Horses With Osteoarthritis - TheHorse.com - June 12th, 2020
- Why Do Some People Get Sick All the Time, While Others Stay in Freakishly Good Health? - Discover Magazine - June 12th, 2020
- How safe are Ohio summer fun activities amid the coronavirus threat? The Wake Up for Friday, May 29, 2020 - cleveland.com - May 31st, 2020
- Kenneth Wallace Promoted to Full Professor at Clarkson University - Clarkson University News - May 31st, 2020
- ODDS AND ENDS: Melonheads and other offbeat offerings - Toronto Sun - May 31st, 2020
- OHIO researchers win grant to study treatment for possible fatal complications of COVID-19 - Huntington Herald Dispatch - May 8th, 2020
- Coronavirus Today: We're starting to reopen - Los Angeles Times - May 8th, 2020
- COMMENTARY || Pseudoscience and COVID-19we've had enough already - Folio - University of Alberta - May 3rd, 2020
- This Week in Green Tech: STEM Lessons, Solar Power and the Coronavirus, and More - ENGINEERING.com - May 3rd, 2020
- AskBio Announces First Patient Dosed in Phase 1 Trial Using AAV Gene Therapy for Congestive Heart Failure - BioSpace - February 7th, 2020
- Tune in Tonight: Oscar-nominated The Cave debuts on National Geographic - St. Augustine Record - January 25th, 2020
- Best Stem Cell Therapy Treatment in Cincinnati, Ohio ... - November 28th, 2019
- Time to Try Again: Gene-Based Therapy for Neurodegeneration - Alzforum - November 28th, 2019
- NIA Mourns the Loss of Dr. Huber Warner - National Institute on Aging - November 13th, 2019
- Research Roundup: Genomic Dark Matter Mutation and More - BioSpace - October 23rd, 2019
- Stem Cell Treatment Lima | Orthopaedic Institute of Ohio - September 10th, 2019
- Regenerative Therapy in Northeast Ohio | Ohio Therapy Centers - September 9th, 2019
- Stem cell therapy now available in central Ohio! - May 30th, 2019
- Stem Cell Therapy Clinic in Cleveland, Ohio - March 26th, 2019
- Massages & Treatments | Day Spa on Lake Erie in Ohio | The ... - March 10th, 2019
- *NEW* Regenerative Stem Cell Therapy | Ohio Therapy Centers - December 7th, 2018
- Stem Cell Therapy | Ohio Stem Cell - November 5th, 2018
- Ohio Stem Cell Treatment Center of Cleveland (Beachwood ... - November 3rd, 2018
- Conjoined twins - Wikipedia - September 20th, 2018
- Government website steers patients to unproven medical treatments - MyAJC - September 2nd, 2017
- Modern Health & Wellness of Lima institutes regenerative stem cell therapy - Lima Ohio - September 2nd, 2017
- 'Nanotransfection' Turns Animal Skin into Blood Vessels and Brain ... - Medical Device and Diagnostics Industry - August 26th, 2017
- This Chip Uses Electricity to Reprogram Cells for Healing - Singularity Hub - August 25th, 2017
- This year's freshman class at Misericordia University is third largest in school history - The Dallas Post - August 25th, 2017
- Nanochip Could Heal Injuries or Regrow Organs with One Touch - NewsFactor Network - August 18th, 2017
- Wild new microchip tech could grow brain cells on your skin - CNET - August 8th, 2017
- Researchers explore possible alternative to knee replacement - Scope (blog) - August 5th, 2017
- Jackson Twp.'s Emmie Wanzer loves her new wheelchair swing provided by Wishes Can Happen Wanzer - Canton Repository - July 4th, 2017
- Scientists Discover That Fasting Triggers Stem Cell ... - November 23rd, 2016
- Stem-Cells | The Institute for Applied & Professional Ethics - November 18th, 2016
- Stem Cell Transplant Program - Cleveland, Ohio - October 17th, 2016
- Update: Ohio Stem Cell Study Recruiting People with MS ... - October 17th, 2016
- National Center For Regenerative Medicine - October 17th, 2016
- Stem-cell niche - Wikipedia, the free encyclopedia - October 19th, 2015
- Alex Potoczak of Ohio Praises Umbilical Stem Cell Research ... - July 2nd, 2015
- Dr. Foglietti | Ohio Stem Cell Treatment Center of Cleveland - April 27th, 2015
- Taubman Institute Receives $3 Million Wexner Gift to Support Emerging Physician-Researchers - April 3rd, 2015
- Morgan's Fund Launches Necrotizing Enterocolitis (NEC) Podcast Series: Premiere Features Dr. Gail Besner - March 24th, 2015
- Ohio Stem Cell Knee Arthritis Treatment-Regenexx - February 23rd, 2015
- We Were Promised Space Lasers: The State of the Union's Biggest Fibs - January 21st, 2015
- We Were Promised Space Lasers: State of the Union's Biggest Fibs - January 20th, 2015
- We Were Promised Space Lasers: The State of the Union's Big Fibs - January 17th, 2015
- 'Unprecedented': Drug May Help Heal Damaged Spines - December 4th, 2014
- New DNA discovery could lead to chromosome therapies in the future - November 19th, 2014
- Tiny Stomachs Grown in the Lab - October 31st, 2014
- Stem Cells Used to Grow Mini-Stomachs Seeking Treatments - October 30th, 2014
- Scientists build 'mini-stomachs' in lab - October 30th, 2014